Advertisement
Nuplazid (pimavanserin) has been approved by the U.S. Food and Drug Administration to treat hallucinations and delusions associated with Parkinson's disease.

FDA Approves Nuplazid for Parkinson’s Hallucinations

0
Half of patients with Parkinson's may experience hallucinations, delusions
Mandatory safety training for doctors who prescribe opioids is being reconsidered by the U.S. Food and Drug Administration.

FDA Reconsidering Training for Doctors Prescribing Opioids

0
Next week, FDA committee of outside experts will meet to review risk-management plans
Health care prices vary widely across the United States

Wide Variation in Health Care Costs Across the U.S.

0
Even within a state, there can be large differences in price
New research suggests that hearing aids might help prevent or slow the development of dementia in elderly people with hearing loss. The study was published online April 25 in the American Journal of Geriatric Psychiatry.

Hearing Aids Linked to Stronger Scores on Mini-Mental Exam

0
Ability to stay engaged in conversation could help ward off dementia, study suggests
There is a lack of data relating to the prevalence of workplace violence in health care and how to address it

Article Discusses Workplace Violence in Health Care

0
Workplace violence often underreported; health care sector among industries most subject to violence
Rosacea may be linked to a higher risk for dementia

Rosacea Linked to Increased Risk of Dementia

0
Alzheimer's disease, in particular
Under the Physician Payments Sunshine Act

Doctors Have a Only a Few Weeks Left to Review Financial Data

0
Physicians have a few weeks left to review, dispute reports relating to their financial ties to industry
An update on Americans' health finds that racial and ethnic disparities persist

U.S. Health Report Card Finds Racial, Ethnic Disparities Persist

0
But infant mortality rates, numbers of uninsured are improving, government analysis reveals
The prevalence of migraine headache is elevated in patients with cardiac syndrome X compared to patients with coronary artery disease or healthy controls

Prevalence of Migraine Up in Patients With Cardiac Syndrome X

0
Increased prevalence in CSX compared with coronary artery disease or healthy controls
The drug eteplirsen should not be approved for treatment of Duchenne muscular dystrophy

FDA Panel Votes Against Approval of Eteplirsen for DMD

0
Clinical data did not meet the agency's requirements for well controlled studies necessary for approval